Cargando…

Diabetic Foot Risk Classification at the Time of Type 2 Diabetes Diagnosis and Subsequent Risk of Mortality: A Population-Based Cohort Study

AIM: We aimed to compare the mortality of individuals at low, moderate, and high risk of diabetic foot disease (DFD) in the context of newly diagnosed type 2 diabetes, before developing active diabetic foot problem. METHODS: This was a population-based cohort study of adults with newly diagnosed typ...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhaonan, Hazlehurst, Jonathan, Subramanian, Anuradhaa, Tahrani, Abd A., Hanif, Wasim, Thomas, Neil, Singh, Pushpa, Wang, Jingya, Sainsbury, Christopher, Nirantharakumar, Krishnarajah, Crowe, Francesca L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309507/
https://www.ncbi.nlm.nih.gov/pubmed/35898465
http://dx.doi.org/10.3389/fendo.2022.888924
_version_ 1784753179440709632
author Wang, Zhaonan
Hazlehurst, Jonathan
Subramanian, Anuradhaa
Tahrani, Abd A.
Hanif, Wasim
Thomas, Neil
Singh, Pushpa
Wang, Jingya
Sainsbury, Christopher
Nirantharakumar, Krishnarajah
Crowe, Francesca L.
author_facet Wang, Zhaonan
Hazlehurst, Jonathan
Subramanian, Anuradhaa
Tahrani, Abd A.
Hanif, Wasim
Thomas, Neil
Singh, Pushpa
Wang, Jingya
Sainsbury, Christopher
Nirantharakumar, Krishnarajah
Crowe, Francesca L.
author_sort Wang, Zhaonan
collection PubMed
description AIM: We aimed to compare the mortality of individuals at low, moderate, and high risk of diabetic foot disease (DFD) in the context of newly diagnosed type 2 diabetes, before developing active diabetic foot problem. METHODS: This was a population-based cohort study of adults with newly diagnosed type 2 diabetes utilizing IQVIA Medical Research Data. The outcome was all-cause mortality among individuals with low, moderate, and high risk of DFD, and also in those with no record of foot assessment and those who declined foot examination. RESULTS: Of 225,787 individuals with newly diagnosed type 2 diabetes, 34,061 (15.1%) died during the study period from January 1, 2000 to December 31, 2019. Moderate risk and high risk of DFD were associated with increased mortality risk compared to low risk of DFD (adjusted hazard ratio [aHR] 1.50, 95% CI 1.42, 1.58; aHR 2.01, 95% CI 1.84, 2.20, respectively). Individuals who declined foot examination or who had no record also had increased mortality risk of 75% and 25% vs. those at low risk of DFD, respectively (aHR 1.75, 95% CI 1.51, 2.04; aHR 1.25, 95% CI 1.20, 1.30). CONCLUSION: Individuals with new-onset type 2 diabetes who had moderate to high risk of DFD were more likely to die compared to those at low risk of DFD. The associations between declined foot examination and absence of foot examinations, and increased risk of mortality further highlight the importance of assessing foot risk as it identifies not only patients at risk of diabetic foot ulceration but also mortality.
format Online
Article
Text
id pubmed-9309507
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93095072022-07-26 Diabetic Foot Risk Classification at the Time of Type 2 Diabetes Diagnosis and Subsequent Risk of Mortality: A Population-Based Cohort Study Wang, Zhaonan Hazlehurst, Jonathan Subramanian, Anuradhaa Tahrani, Abd A. Hanif, Wasim Thomas, Neil Singh, Pushpa Wang, Jingya Sainsbury, Christopher Nirantharakumar, Krishnarajah Crowe, Francesca L. Front Endocrinol (Lausanne) Endocrinology AIM: We aimed to compare the mortality of individuals at low, moderate, and high risk of diabetic foot disease (DFD) in the context of newly diagnosed type 2 diabetes, before developing active diabetic foot problem. METHODS: This was a population-based cohort study of adults with newly diagnosed type 2 diabetes utilizing IQVIA Medical Research Data. The outcome was all-cause mortality among individuals with low, moderate, and high risk of DFD, and also in those with no record of foot assessment and those who declined foot examination. RESULTS: Of 225,787 individuals with newly diagnosed type 2 diabetes, 34,061 (15.1%) died during the study period from January 1, 2000 to December 31, 2019. Moderate risk and high risk of DFD were associated with increased mortality risk compared to low risk of DFD (adjusted hazard ratio [aHR] 1.50, 95% CI 1.42, 1.58; aHR 2.01, 95% CI 1.84, 2.20, respectively). Individuals who declined foot examination or who had no record also had increased mortality risk of 75% and 25% vs. those at low risk of DFD, respectively (aHR 1.75, 95% CI 1.51, 2.04; aHR 1.25, 95% CI 1.20, 1.30). CONCLUSION: Individuals with new-onset type 2 diabetes who had moderate to high risk of DFD were more likely to die compared to those at low risk of DFD. The associations between declined foot examination and absence of foot examinations, and increased risk of mortality further highlight the importance of assessing foot risk as it identifies not only patients at risk of diabetic foot ulceration but also mortality. Frontiers Media S.A. 2022-07-11 /pmc/articles/PMC9309507/ /pubmed/35898465 http://dx.doi.org/10.3389/fendo.2022.888924 Text en Copyright © 2022 Wang, Hazlehurst, Subramanian, Tahrani, Hanif, Thomas, Singh, Wang, Sainsbury, Nirantharakumar and Crowe https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Wang, Zhaonan
Hazlehurst, Jonathan
Subramanian, Anuradhaa
Tahrani, Abd A.
Hanif, Wasim
Thomas, Neil
Singh, Pushpa
Wang, Jingya
Sainsbury, Christopher
Nirantharakumar, Krishnarajah
Crowe, Francesca L.
Diabetic Foot Risk Classification at the Time of Type 2 Diabetes Diagnosis and Subsequent Risk of Mortality: A Population-Based Cohort Study
title Diabetic Foot Risk Classification at the Time of Type 2 Diabetes Diagnosis and Subsequent Risk of Mortality: A Population-Based Cohort Study
title_full Diabetic Foot Risk Classification at the Time of Type 2 Diabetes Diagnosis and Subsequent Risk of Mortality: A Population-Based Cohort Study
title_fullStr Diabetic Foot Risk Classification at the Time of Type 2 Diabetes Diagnosis and Subsequent Risk of Mortality: A Population-Based Cohort Study
title_full_unstemmed Diabetic Foot Risk Classification at the Time of Type 2 Diabetes Diagnosis and Subsequent Risk of Mortality: A Population-Based Cohort Study
title_short Diabetic Foot Risk Classification at the Time of Type 2 Diabetes Diagnosis and Subsequent Risk of Mortality: A Population-Based Cohort Study
title_sort diabetic foot risk classification at the time of type 2 diabetes diagnosis and subsequent risk of mortality: a population-based cohort study
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309507/
https://www.ncbi.nlm.nih.gov/pubmed/35898465
http://dx.doi.org/10.3389/fendo.2022.888924
work_keys_str_mv AT wangzhaonan diabeticfootriskclassificationatthetimeoftype2diabetesdiagnosisandsubsequentriskofmortalityapopulationbasedcohortstudy
AT hazlehurstjonathan diabeticfootriskclassificationatthetimeoftype2diabetesdiagnosisandsubsequentriskofmortalityapopulationbasedcohortstudy
AT subramaniananuradhaa diabeticfootriskclassificationatthetimeoftype2diabetesdiagnosisandsubsequentriskofmortalityapopulationbasedcohortstudy
AT tahraniabda diabeticfootriskclassificationatthetimeoftype2diabetesdiagnosisandsubsequentriskofmortalityapopulationbasedcohortstudy
AT hanifwasim diabeticfootriskclassificationatthetimeoftype2diabetesdiagnosisandsubsequentriskofmortalityapopulationbasedcohortstudy
AT thomasneil diabeticfootriskclassificationatthetimeoftype2diabetesdiagnosisandsubsequentriskofmortalityapopulationbasedcohortstudy
AT singhpushpa diabeticfootriskclassificationatthetimeoftype2diabetesdiagnosisandsubsequentriskofmortalityapopulationbasedcohortstudy
AT wangjingya diabeticfootriskclassificationatthetimeoftype2diabetesdiagnosisandsubsequentriskofmortalityapopulationbasedcohortstudy
AT sainsburychristopher diabeticfootriskclassificationatthetimeoftype2diabetesdiagnosisandsubsequentriskofmortalityapopulationbasedcohortstudy
AT nirantharakumarkrishnarajah diabeticfootriskclassificationatthetimeoftype2diabetesdiagnosisandsubsequentriskofmortalityapopulationbasedcohortstudy
AT crowefrancescal diabeticfootriskclassificationatthetimeoftype2diabetesdiagnosisandsubsequentriskofmortalityapopulationbasedcohortstudy